The store will not work correctly when cookies are disabled.
5-(methylsulfonyl)-2-(5-(4-(thiazol-2-yl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
ID: ALA383210
Chembl Id: CHEMBL383210
PubChem CID: 18768833
Max Phase: Preclinical
Molecular Formula: C19H13F3N4O2S2
Molecular Weight: 450.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3nccs3)cc2)nc1
Standard InChI: InChI=1S/C19H13F3N4O2S2/c1-30(27,28)14-6-7-17(24-11-14)26-15(10-16(25-26)19(20,21)22)12-2-4-13(5-3-12)18-23-8-9-29-18/h2-11H,1H3
Standard InChI Key: KBRVQKZQCHBCQF-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 450.47 | Molecular Weight (Monoisotopic): 450.0432 | AlogP: 4.48 | #Rotatable Bonds: 4 |
Polar Surface Area: 77.74 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.60 | CX LogP: 3.79 | CX LogD: 3.79 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.46 | Np Likeness Score: -2.01 |
References
1. Cheng H, Lundy DeMello KM, Li J, Sakya SM, Ando K, Kawamura K, Kato T, Rafka RJ, Jaynes BH, Ziegler CB, Stevens R, Lund LA, Mann DW, Kilroy C, Haven ML, Nimz EL, Dutra JK, Li C, Minich ML, Kolosko NL, Petras C, Silvia AM, Seibel SB.. (2006) Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors., 16 (8): [PMID:16464588] [10.1016/j.bmcl.2006.01.059] |